Betaloc

Betaloc

metoprolol

Manufacturer:

AstraZeneca

Distributor:

Zuellig
Concise Prescribing Info
Contents
Metoprolol tartrate
Indications/Uses
HTN. Angina pectoris. Disturbances of cardiac rhythm including supraventricular tachycardia. Maintenance treatment after MI. Functional heart disorders w/ palpitations. Migraine prophylaxis. Hyperthyroidism.
Dosage/Direction for Use
HTN 100-200 mg daily, as a single dose in the morning or in divided doses (morning & evening). If needed, other antihypertensives may be added. Angina pectoris, cardiac arrhythmias 100-200 mg daily in divided doses (morning & evening). If needed, other antianginal or other antiarrhythmics may be added. Maintenance treatment after MI 200 mg daily in divided doses (morning & evening). Functional heart disorders w/ palpitations 100 mg once daily in the morning, may be increased to 200 mg if needed. Migraine prophylaxis 100-200 mg daily in divided doses (morning & evening). Hyperthyroidism 150-200 mg daily in 3-4 doses, may increase dose if needed.
Administration
Should be taken on an empty stomach.
Contraindications
Hypersensitivity metoprolol or to other β-blockers. AV block of 2nd or 3rd degree; unstable decompensated cardiac failure (pulmonary oedema, hypoperfusion or hypotension), continuous or intermittent inotropic therapy; sinus bradycardia, sick-sinus syndrome, cardiogenic shock; severe peripheral arterial circulatory disorder. Suspected acute MI w/ heart rate <45 beats/min, P-Q interval >0.24 sec or systolic BP <100 mmHg.
Special Precautions
Concomitant use w/ verapamil-type Ca antagonists. Asthma. Risk of interfering w/ carbohydrate metabolism or masking hypoglycemia. Patient w/ heart failure should  have their decompensation treated before & during treatment. May aggravate preexisting AV conduction disorder of moderate degree; symptom of peripheral arterial circulatory disorders. Patients who develop increasing bradycardia; may aggravate symptoms of peripheral arterial circulatory disorders; pheochromocytoma. Avoid abrupt w/drawal. Patients w/ known ischemic heart disease. Do not stop in patients undergoing surgery. Avoid acute initiation of high doses to patients undergoing non-cardiac surgery. Anaphylactic shock. May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Fatigue. Bradycardia, postural disorders, cold hands & feet, palpitations; dizziness, headache; nausea, abdominal pain, diarrhea & constipation; dyspnoea on exertion.
Drug Interactions
May raise plasma levels w/ drugs metabolized w/ CYP2D6 eg, antiarrhythmics, antihistamines, histamine-2-receptor antagonists, antidepressants, antipsychotics & COX-2-inhibitors. Lowered plasma conc w/ rifampicin. Raised plasma conc w/ alcohol & hydralazine. Sympathetic ganglion blocking agents, other β-blockers (ie, eye drops), MAOIs, clonidine. Increased -ve inotropic & chronotropic effects w/ Ca antagonists of verapamil & diltiazem type. May enhance -ve inotropic & dromotropic effect of quinidine & amiodarone type antiarrhythmics. Increased AV conduction time & induce bradycardia w/ digitalis glycosides. Enhanced cardiodepressant effect w/ inhalation anaesth. May decrease antihypertensive effect w/ indomethacin or other prostaglandin synthetase. Interfered BP control w/ adrenaline. Oral antidiabetics.
MIMS Class
Beta-Blockers
ATC Classification
C07AB02 - metoprolol ; Belongs to the class of selective beta-blocking agents. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Betaloc tab 100 mg
Packing/Price
105's
Form
Betaloc tab 50 mg
Packing/Price
100's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in